CLEC12A and neoplasm: This anti-CCL1 CAR T cell showed the in vitro and in vivo strong functionality against CLL1+ tumor cells with a wide production of effector cytokines and chemokines including GM-CSF, TNF-α, IFN-γ, and IL-13 [97].